 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jul 01, 2011 |
| Title |
Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Background: Atopic dermatitis (AD) is a common inflammatory skin disease exhibiting a predominantly Th2/“T22” immune activation and a defective epidermal barrier. Narrow-band UVB (NB-UVB) is considered an efficient treatment for moderate to severe AD. In psoriasis, NB-UVB has been found to suppress the Th1/Th17 immune polarization with subsequent reversal of epidermal hyperplasia. The immunomodulatory effects of this treatment are largely unknown in AD. Our study evaluates the effects of NB-UVB on immune and barrier abnormalities in AD, aiming to establish reversibility of disease and biomarkers of therapeutic response. Methods: 12 moderate-to-severe chronic AD patients received NB-UVB phototherapy 3 times weekly for up to 12 weeks. Lesional and non-lesional skin biopsies were obtained before and after treatment and evaluated by gene-expression and immunohistochemistry studies. Results: All patients had at least a 50% reduction in SCORing of AD (SCORAD) index with NB-UVB phototherapy. The Th2, T22, and Th1 immune pathways were suppressed and measures of epidermal hyperplasia and differentiation also normalized after phototherapy. The reversal of disease activity was associated with elimination of inflammatory leukocytes, Th2/“T22”-associated cytokines and chemokines, and normalized expression of barrier proteins. Conclusions: Our study shows reversal of both the epidermal defects and underlying immune activation in AD. By determining the correlation of variables with therapeutic response, we have defined a set of biomarkers of disease response that associate resolved Th2 and T22 inflammation with reversal of barrier pathology. This data supports the “inside-out” hypothesis of AD, suggesting that it is a disease primarily driven by an immune stimulus.
|
| |
|
| Overall design |
genomic profiling of treatment effect of NB-UVB in AD in both lesional and non-lesional AD skin from 10 patients.
Treatment effect , disease state analysis
|
| |
|
| Contributor(s) |
Suárez-Fariñas M, Guttman-Yasky E |
| Citation(s) |
21762976 |
| |
| Submission date |
Mar 10, 2011 |
| Last update date |
Mar 25, 2019 |
| Contact name |
Mayte Suarez-Farinas |
| E-mail(s) |
mayte.suarezfarinas@mssm.edu
|
| Organization name |
Mount SinaiSchool of Medicine
|
| Street address |
1425 Madison Ave, L2-70C, Box 1077,
|
| City |
New York |
| State/province |
NY |
| ZIP/Postal code |
10075 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
| Samples (35)
|
| GSM688741 |
P1, POST, AL lesional |
| GSM688742 |
P10, POST, ANL non-lesional |
| GSM688743 |
P10, POST, AL lesional |
| GSM688744 |
P2, POST, ANL non-lesional |
| GSM688745 |
P2, POST, AL lesional |
| GSM688746 |
P4, POST, ANL non-lesional |
| GSM688747 |
P4, POST, AL lesional |
| GSM688748 |
P6, POST, ANL non-lesional |
| GSM688749 |
P6, POST, AL lesional |
| GSM688750 |
P5, POST, ANL non-lesional |
| GSM688751 |
P5, POST, AL lesional |
| GSM688752 |
P8, POST, ANL non-lesional |
| GSM688753 |
P8, POST, AL lesional |
| GSM688754 |
P3, POST, ANL non-lesional |
| GSM688755 |
P3, POST, AL lesional |
| GSM688756 |
P7, PRE, ANL non-lesional |
| GSM688757 |
P7, PRE, AL lesional |
| GSM688758 |
P9, PRE, ANL non-lesional |
| GSM688759 |
P9, PRE, AL lesional |
| GSM688760 |
P1, PRE, ANL non-lesional |
| GSM688761 |
P1, PRE, AL lesional |
| GSM688762 |
P10, PRE, ANL non-lesional |
| GSM688763 |
P10, PRE, AL lesional |
| GSM688764 |
P2, PRE, ANL non-lesional |
| GSM688765 |
P2, PRE, AL lesional |
| GSM688766 |
P4, PRE, ANL non-lesional |
| GSM688767 |
P4, PRE, AL lesional |
| GSM688768 |
P6, PRE, AL lesional |
| GSM688769 |
P5, PRE, ANL non-lesional |
| GSM688770 |
P8, PRE, AL lesional |
| GSM688771 |
P3, PRE, ANL non-lesional |
| GSM688772 |
P3, PRE, AL lesional |
|
| Relations |
| BioProject |
PRJNA138001 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE27887_RAW.tar |
186.2 Mb |
(http)(custom) |
TAR (of CEL) |
| Processed data included within Sample table |
|
|
|
|
 |
Less...
More...